Health Condition 1: I10-I16- Hypertensive diseases
Conditions
Interventions
Intervention1: L-Arginine Granules: German Remedies Ahmadabad will supply the required sachet of Gyargin (L- Arginine granules)
Each 5gram sachet contains
L- Arginine IP 3g
Excipients q.s
Frequency
Sponsors
Pravara Institute Of Medical Sciences Loni
Eligibility
Inclusion criteria
Inclusion criteria: All the patients of hypertension taking anti- hypertensive drugs since last sixth months Adult patients between 18-60years Patients of either gender Patient ready to give written informed consent and willing to participate in the trial
Exclusion criteria
Exclusion criteria: Patient suffering from Gestational hypertension Patients suffering from hypertension with Brain disorders Patients with history of thyroid disorders and taking anti-epileptic medication Patients on chronic medications other than anti-hypertensive drugs Use of any drug that may affect nitric oxide synthesis (nitrates, CNS depressant, steroids) Patients with history of Diabetes mellitus Renal failure patients Patient with history of ischemic heart disease, Transient ischemic attack (TIA), Stroke or peripheral arterial disease Patients with history of recurrent herpes Patients with history of Cancer treated with radiotherapy or chemotherapy during the last year
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Measure changes in systolic blood pressure and Diastolic blood pressure with L-Arginine therapy in hypertensive patients on anti-hypertensive medication.Timepoint: The expected outcome will be measured from Baseline visit i.e on 0day,7thday,14thday and 21thday. | — |
Secondary
| Measure | Time frame |
|---|---|
| To measure other clinical,Physiological benefits of add on therapy with L-Arginine in patients of hypertensionTimepoint: After 21 days | — |
Countries
India
Contacts
Public ContactMrs Pulate Vandana Shridhar
Pravara Institute Of Medical Sciences Loni
Outcome results
None listed